HEIDELBERG, Germany, Dec. 25, 2024 — European Wellness Biomedical Group (EWBG) has initiated a research program concentrating on Klotho, a protein with significant potential in longevity medicine. Under the direction of Professor Dr. Mike Chan, this undertaking will investigate Klotho’s role in mitigating age-related illnesses and its capacity to regenerate vital organs, such as the brain, kidneys, and heart.

Klotho, discovered in 1997, is emerging as a crucial protein in longevity and regenerative medicine. It plays a key regulatory role in oxidative stress, mineral metabolism, and inflammation. The research will explore how increasing Klotho levels could help manage chronic conditions such as neurodegenerative diseases, kidney failure, and heart disease, ultimately enhancing healthspan and lifespan.

“Klotho represents the next frontier in longevity medicine,” stated Professor Mike Chan, Chief Scientist at EWBG. “Our research aims to understand Klotho’s impact on aging and how we can utilize it to treat chronic diseases often associated with aging.”

Research Focus Areas

This new initiative will concentrate on three main research areas:

• Neurological health: Examining Klotho’s neuroprotective effects and its potential to slow cognitive decline in conditions like Alzheimer’s and Parkinson’s.
• Kidney function: Investigating Klotho’s role in regulating mineral metabolism and its regenerative potential in treating chronic kidney disease (CKD).
• Cardiovascular health: Studying Klotho’s impact on vascular function and its capacity to prevent vascular calcification, a major contributor to heart disease.

This research builds upon existing collaborations at EWBG, where leading scientists are focused on advancing Klotho-based therapies for regenerative health.

Klotho: A Potential Breakthrough in Longevity Medicine

Klotho is attracting attention for its ability to regenerate tissues and reverse damage from age-related diseases. Unlike NAD+, which primarily enhances cellular metabolism and energy production, Klotho offers a wider range of therapeutic applications, including tissue regeneration, improved cognitive function, and cardiovascular health.

As we age, Klotho levels naturally decrease, leading to conditions such as cognitive decline, heart disease, and kidney failure. Research suggests that restoring Klotho levels can reverse the effects of oxidative stress, inflammation, and cellular senescence, providing new treatment options for various age-related diseases.

Professor Mike Chan: Leading the Charge in Klotho Research

Professor Mike Chan, a leading expert in stem cell therapy and longevity medicine, is leading this groundbreaking initiative at EWBG. His extensive experience in bio-regenerative medicine positions him as a key figure in exploring Klotho’s potential to revolutionize the treatment of age-related diseases. Through FCTI, an EWBG subsidiary, Professor Chan and his team are developing therapies combining stem cell technology and Klotho proteins to stimulate tissue regeneration in the brain, kidneys, and heart.

“By harnessing Klotho’s regenerative properties, we aim to address chronic conditions previously considered untreatable,” said Professor Chan. “Our ultimate objective is to improve quality of life and offer lasting solutions for those affected by age-related diseases.”

The Future of Klotho in Longevity Medicine

The future of Klotho-based therapies appears promising, with Professor Mike Chan and EWBG at the forefront of this innovative field. As more research is conducted, Klotho is expected to play a vital role in advancing longevity medicine, offering a novel approach to treating aging and chronic diseases. The potential applications of Klotho are extensive, ranging from neurodegenerative disease treatment to kidney regeneration and cardiovascular health.

With strong research partnerships, substantial funding, and ongoing clinical trials, Klotho is poised to become a cornerstone of longevity medicine, transforming how we approach aging and disease. Professor Mike Chan’s leadership ensures that this promising protein will soon offer new hope for those seeking longer, healthier lives.

Photo –

Logo – 

“`